Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?

Line Raaby; Stina Lou; Rikke Ramløv Lodberg Ivarsen; Jette Sørensen; Ole Halfdan Larsen; Ida Vogel

Objective

Genetic high-resolution analyses and improved diagnostic imaging have impacted the ability to detect fetal disorders. It is unknown if this resulted in an alteration in the number of terminations of pregnancy due to fetal anomalies (TOPFA). The objective was to describe the incidence and indication of TOPFA.

Methods

A descriptive study based on records from the Regional Abortion Council in the Central Denmark Region from 2008 to 2021 consisting of 1895 TOPFA.

Results

A consistent incidence of TOPFA was observed, accounting for 0.96% of the total births during that period. When examining fetal indications, there was a small increase in the occurrence of genetic aberrations, primarily caused by deletions, duplications, and single nucleotide variations, whereas the number of chromosomal aberrations remained stable. Of 35.5% of the cases with malformations, the central nervous system was the most affected organ system, followed by malformations of the heart 29.6%. Overall, the total number of cases remained stable.

Discussion and conclusion

Unexpectedly, despite the development of new diagnostic tools, the incidence of TOPFA from 2008 to 2021 remained stable. However, the number of cases with genetic aberrations increased. This may be attributed to increased genetic testing for fetuses with identified malformations, resulting in more accurate diagnoses.

Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?

Udgivelsesform Videnskabelige artikler
År 2024
Udgiver Prenatal Diagnosis

Kontaktperson

Stina Lou

Stina Lou

+45 7841 4364

stisoe@rm.dk

Forfattere

Stina Lou